Eagle Pharmaceuticals, Inc. Royalty Revenue (Deprecated 2018-01-31)
Eagle Pharmaceuticals, Inc. reported Royalty Revenue (Deprecated 2018-01-31) of $35.79 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Income Statement › Other Income
us-gaap:RoyaltyRevenue · last filed 2018-05-10
- Eagle Pharmaceuticals, Inc. royalty revenue (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $35.79M, a 1.97% decline year-over-year.
- Eagle Pharmaceuticals, Inc. royalty revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $36.35M, a 13.55% increase year-over-year.
- Eagle Pharmaceuticals, Inc. royalty revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $43.62M, a 66.18% increase year-over-year.
- Eagle Pharmaceuticals, Inc. royalty revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $37.40M, a 19.46% increase year-over-year.
- Eagle Pharmaceuticals, Inc. royalty revenue (deprecated 2018-01-31) for fiscal 2017 was $153.88M, a 55.37% increase from fiscal 2016.
- Eagle Pharmaceuticals, Inc. royalty revenue (deprecated 2018-01-31) for fiscal 2016 was $99.04M, a 1099.18% increase from fiscal 2015.
- Eagle Pharmaceuticals, Inc. royalty revenue (deprecated 2018-01-31) for fiscal 2015 was $8.26M.
- Eagle Pharmaceuticals, Inc. royalty revenue (deprecated 2018-01-31) for fiscal 2014 was $10.71M, a 28.02% increase from fiscal 2013.
| Period end | Royalty Revenue (Deprecated 2018-01-31) 3 month | Royalty Revenue (Deprecated 2018-01-31) 3 month as first filed | Royalty Revenue (Deprecated 2018-01-31) 6 month | Royalty Revenue (Deprecated 2018-01-31) 9 month | Royalty Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2018-03-31 | $35.79M 10-Q · filed 2018-05-10 | $72.14M derived: sum of 2 quarters · filed 2018-05-10 | $115.76M derived: sum of 3 quarters · filed 2018-05-10 | $153.16M derived: sum of 4 quarters · filed 2018-05-10 | |
| 2017-12-31 | $36.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $79.97M derived: sum of 2 quarters · filed 2018-02-26 | $117.37M derived: sum of 3 quarters · filed 2018-02-26 | $153.88M 10-K · filed 2018-02-26 | |
| 2017-09-30 | $43.62M 10-Q · filed 2017-11-08 | $81.02M derived: sum of 2 quarters · filed 2017-11-08 | $117.53M 10-Q · filed 2017-11-08 | $149.54M derived: sum of 4 quarters · filed 2018-05-10 | |
| 2017-06-30 | $37.40M 10-Q · filed 2017-08-09 | $73.91M 10-Q · filed 2017-08-09 | $105.93M derived: sum of 3 quarters · filed 2018-05-10 | $132.17M derived: sum of 4 quarters · filed 2018-05-10 | |
| 2017-03-31 | $36.51M 10-Q · filed 2018-05-10 | $68.52M derived: sum of 2 quarters · filed 2018-05-10 | $94.77M derived: sum of 3 quarters · filed 2018-05-10 | $126.08M derived: sum of 4 quarters · filed 2018-05-10 | |
| 2016-12-31 | $32.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $58.26M derived: sum of 2 quarters · filed 2018-02-26 | $89.57M derived: sum of 3 quarters · filed 2018-02-26 | $99.04M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $26.25M 10-Q · filed 2017-11-08 | $57.56M derived: sum of 2 quarters · filed 2017-11-08 | $67.03M 10-Q · filed 2017-11-08 | $67.34M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2016-06-30 | $31.31M 10-Q · filed 2017-08-09 | $40.78M 10-Q · filed 2017-08-09 | $41.09M derived: sum of 3 quarters · filed 2018-02-26 | $43.51M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2016-03-31 | $9.47M 10-Q · filed 2017-05-08 | $9.78M derived: sum of 2 quarters · filed 2018-02-26 | $12.20M derived: sum of 3 quarters · filed 2018-02-26 | $14.47M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2015-12-31 | $312.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $2.73M derived: sum of 2 quarters · filed 2018-02-26 | $5.01M derived: sum of 3 quarters · filed 2018-02-26 | $8.26M 10-K · filed 2018-02-26 | |
| 2015-09-30 | $2.42M 10-Q · filed 2016-11-09 | $4.69M derived: sum of 2 quarters · filed 2016-11-09 | $7.95M 10-Q · filed 2016-11-09 | $12.04M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2015-06-30 | $2.27M 10-Q · filed 2016-08-09 | $5.53M 10-Q · filed 2016-08-09 | $9.62M derived: sum of 3 quarters · filed 2017-03-15 | $11.55M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2015-03-31 | $3.25M 10-Q · filed 2016-05-10 | $7.35M derived: sum of 2 quarters · filed 2017-03-15 | $9.28M derived: sum of 3 quarters · filed 2017-03-15 | $11.22M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2014-12-31 | $4.09M 10-K · filed 2017-03-15 | $6.03M derived: sum of 2 quarters · filed 2017-03-15 | $7.97M derived: sum of 3 quarters · filed 2017-03-15 | $11.54M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2014-09-30 | $1.93M 10-Q · filed 2015-11-12 | $3.88M derived: sum of 2 quarters · filed 2015-11-12 | $7.44M 10-Q · filed 2015-11-12 | $10.71M 10-K · filed 2017-03-15 | |
| 2014-06-30 | $1.94M 10-Q · filed 2015-08-11 | $1.94M 10-Q · filed 2014-08-11 | $5.51M 10-Q · filed 2015-08-11 | $8.77M 10-Q · filed 2014-08-11 | $11.79M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-03-31 | $3.56M 10-Q · filed 2015-05-15 | $3.56M 10-Q · filed 2014-05-15 | $6.83M 10-Q · filed 2014-05-15 | $9.85M derived: sum of 3 quarters · filed 2017-03-15 | $12.43M derived: sum of 4 quarters · filed 2017-03-15 |
| 2013-12-31 | $3.27M 10-K · filed 2017-03-15 | $6.28M derived: sum of 2 quarters · filed 2017-03-15 | $8.87M derived: sum of 3 quarters · filed 2017-03-15 | $10.40M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2013-09-30 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $5.60M derived: sum of 2 quarters · filed 2016-02-29 | $7.14M derived: sum of 3 quarters · filed 2016-02-29 | $8.36M 10-K · filed 2016-02-29 | |
| 2013-06-30 | $2.59M 10-Q · filed 2014-08-11 | $4.12M derived: sum of 2 quarters · filed 2014-08-11 | $5.35M 10-Q · filed 2014-08-11 | ||
| 2013-03-31 | $1.54M 10-Q · filed 2014-05-15 | $2.76M 10-Q · filed 2014-05-15 | |||
| 2012-09-30 | $1.38M 10-K · filed 2014-12-22 |